Clinical Trial Update: A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical evaluation of Baofeikang Granule for Combined Pulmonary Fibrosis and Emphysema; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Pulmonary Fibrosis and Emphysema

Drugs mentioned

• Baofeikang Granule

Snippet

Sponsor: Beijing Municipal Science & Technology Commission | Conditions: Combined Pulmonary Fibrosis and Emphysema | Phase 2 | Status: UNKNOWN